The Novita Healthcare Ltd (ASX: NHL) share price has been racing higher again on Wednesday.
In afternoon trade the early childhood technology company’s shares are up a further 33% to 9.9 cents.
This latest gain means that its shares are now up a staggering 900% since this time last month.
Why is the Novita Healthcare share price rocketing higher?
Investors have been fighting to get hold of the company’s shares over the last couple of weeks thanks to updates on its TALi Detect and TALi Train programs.
TALi Detect is a 20-min digital game-based screening tool available to all children to assess potential attention deficits.
TALi Train is a 25-session intensive digital program. It strengthens children’s three core attention skills – Selective Attention, Sustained Attention and Executive Attention.
Both programs have recently received determinations that they can be delivered via the U.S. Reimbursement Code system.
Managing Director, Glenn Smith, explained why this is such a big positive.
He said: “The U.S. clinical market represents a massive opportunity for TALi and leveraging this CPT Code will assist us in securing relevant channel partners and customers in order to realise that opportunity. On average, in the U.S., every classroom of 30 students has up to 3 children with ADHD with 6.1m children diagnosed with ADHD currently in the U.S. As such, we are committed to ensuring that children have access to the TALi technology platform as we believe the technology can significantly improve their lives and reduce health care expenditure.”
“TALi Train is currently the only regulatory cleared early childhood digital cognitive assessment and training program and with all development and compliance requirements achieved we are now set to execute on our go to market strategy to realise the potential of this world-leading technology,” Mr Smith added.
What now for Novita Healthcare?
The company intends to provide further guidance on the deployment and billing schedule in the near future.
It is currently engaging with physicians, customers, and any potential partners in the United States. This is in preparation for a launch over the coming quarters.
This could mean it won’t be too long before Novita Healthcare is generating revenues. Though, given its relatively slender cash balance, I suspect a capital raising may be on the horizon.
Novita isn’t the only small cap on the rise today. Both Bubs Australia Ltd (ASX: BUB) and Pushpay Holdings Ltd (ASX: PPH) are pushing higher after positive announcements.
The post Why the Novita Healthcare share price is up 900% in a month appeared first on Motley Fool Australia.
Whilst Novita could be one to watch, I would sooner be a buyer of these exciting shares which have been tipped to smash the market in 2020.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia has recommended BUBS AUST FPO and PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019